SHANGHAI, China, April 24, 2018 -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that members of the senior management team will participate at two upcoming investor conferences. Details of the presentations are as follows:
J.P. Morgan’s Global China Summit
Panel: Innovative Healthcare Panel
Date: Tuesday, May 8, 2018
Location: Beijing, China
Panel Time: 4:00pm CST
Bank of America Merrill Lynch Healthcare Conference
Date: Thursday, May 17, 2018
Location: Las Vegas, Nevada
Presentation Time: 8:00am PST
Individuals may access a live webcast of the Bank of America Merrill Lynch Healthcare Conference presentation on the Zai Lab website at www.zailaboratory.com under "Events & Presentations" in the "Investors" section. A replay of the webcast will be available on this site for 90 days following the live event.
About Zai Lab
Zai Lab (NASDAQ:ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing segments of China’s pharmaceutical market and global unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners’ and its own products in order to impact human health worldwide.
Contact:
Zai Lab
Billy Cho
+86 137 6151 2501
[email protected]
Solebury Trout
John Graziano
+1 646 378 2942
[email protected]


Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Bain Capital Secures RBI Approval to Acquire Up to 41.7% Stake in Manappuram Finance
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth
How Marco Pharma International Preserves German Homeopathic Traditions in America
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Mitsui Kinzoku Stock Surges to Record High After Profit Forecast Upgrade and Dividend Increase
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings 



